Asahi Intecc, Eisai and Ohara were among the LPs of Africa-minded AAIC Investment’s second vehicle, following in the footsteps of corporate-backed Samurai Africa Fund 2.
Pharmaceutical firms Asahi Intecc, Eisai Corporation and Ohara Pharmaceutical Industries all committed to Africa Innovation & Healthcare Fund (AFH2), part of Singapore-based investment group AAIC Investment.
Unnamed trading groups filled out the limited partners for the first close of AFH2, which is targeting a $150m final close. Its predecessor AHF1 had raised $47m in 2017, and has backed some 30 companies focusing on healthcare and the United Nations’ Sustainable Development Goals.
AHF2 will continue to identify and back healthtech-minded companies…
